Approval · Notice of Compliance 34292 · 2024
WEGOVY: Notice of Compliance 34292
Issued October 25, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34292
- Date
- October 25, 2024
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and new fill volume
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| WEGOVY | 02552698 | Marketed |
Medicinal ingredients
- SEMAGLUTIDE 0.68 MG per ML